Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 883 | 1,051 | 924 | 1,155 | 1,165 |
| Income taxes - deferred | -13 | -44 | 26 | -60 | 25 |
| Accounts receivable | -309 | -406 | 2,867 | -952 | -590 |
| Other Working Capital | 130 | -883 | 2,515 | -743 | -784 |
| Other Operating Activity | -1,000 | -1,286 | -3,653 | 1,667 | -139 |
| Operating Cash Flow | $-309 | $-1,568 | $2,679 | $1,067 | $-323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -22 | -44 | 108 | 19 |
| Purchase Sale Intangibles | -317 | -350 | -535 | -349 | -424 |
| Investing Cash Flow | $-352 | $-372 | $-579 | $-241 | $-405 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,529 | 990 | -1,611 | 1,609 | 1,188 |
| Debt Issued | 11 | N/A | N/A | 0 | 0 |
| Debt Repayment | -585 | -1,116 | -932 | -1,060 | -1,091 |
| Other Financing Activity | -228 | 1,703 | -226 | -222 | -272 |
| Financing Cash Flow | $727 | $1,577 | $-2,769 | $327 | $-175 |
| Beginning Cash Position | 344 | 707 | 1,376 | 223 | 1,126 |
| End Cash Position | 410 | 344 | 707 | 1,376 | 223 |
| Net Cash Flow | $66 | $-363 | $-669 | $1,153 | $-903 |
| Free Cash Flow | |||||
| Operating Cash Flow | -309 | -1,568 | 2,679 | 1,067 | -323 |
| Capital Expenditure | -353 | -437 | -589 | -349 | -430 |
| Free Cash Flow | -662 | -2,005 | 2,090 | 718 | -753 |